Table 1.

Characteristics of study subjectsa

Age: mean (range)58.0 (43.5–70.8)
Gender: N (%)
 Male22 (55)
 Female18 (45)
Race: N (%)
 White36 (90)
 Black3 (7.5)
 Other1 (2.5)
BMI: mean (range)27.4 (18.1–43.5)
Family history of colorectal cancerb8 (20.0)
Advanced adenomac: N (%)
 Size ≥ 1 cm37 (77.5)
 Tubulovillous/villous18 (45)
 High-grade dysplasia6 (15)
Time from most recent advanced adenoma to receipt of vaccine, days, median (mean, range)572 (824, 168–3,499)
  • aN = 40 (includes 1 patient treated only on week 0).

  • bIn a first-degree relative.

  • cMay meet more than 1 criterion.